Can a physio app keep knee pain patients moving?

NCT ID NCT07842913

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 · Last updated Sep 25, 2026

Summary

Researchers are studying how hybrid telerehabilitation works in routine physiotherapy for adults with anterior knee pain. About 30 participants receive individualized treatment from their physiotherapist, supported by the moveUP mobile app for prescribed exercises, education, communication, and progress tracking. The study follows participants for 72 weeks and measures exercise adherence, pain, knee function, quality of life, and psychological factors. Interviews with patients and physiotherapists explore what helps or hinders using the platform in everyday care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application
What this could lead to
If it works, this could give physiotherapists a practical way to support knee pain exercises between clinic visits and help patients stay on track at home.
What could go wrong
The study is small, with about 30 participants, and it observes how the app is used in routine care rather than comparing it against another treatment. Adherence and outcomes may differ in larger or different patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery. * Access to a smartphone compatible with the moveUP application. Exclusion Criteria: * Currently awaiting spine or lower-limb surgery. * Lower-limb surgery or other invasive intervention within the previous two years. * Joint prosthesis. * Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months. * Saphenous nerve neuritis or Ehlers-Danlos syndrome. * Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection. * Persistent low back pain lasting three months or longer. * Vascular, respiratory, or neurological conditions that interfere with participation. * Cognitive or psychiatric impairment limiting application use or communication. * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anterior knee pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Private clinics

    RECRUITING

    Brussels, Belgium

  • Private clinics

    RECRUITING

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.